CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual
Subscribe to Premium to download historical data

Cash Flow

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Cash flows from operating activities
Net Income
-50,422
-50,422
-27,115
-9,157
-6,019
Depreciation & amortization
887
887
471
128
92
Stock based compensation
6,294
6,294
2,320
271
270
Change in working capital
-2,133
-2,133
5,298
-721
189
Other working capital
-46,873
-46,873
-20,518
-9,783
-5,658
Other non-cash items
222
222
-433
-
-
Net cash provided by operating activites
-46,381
-46,381
-19,459
-9,479
-5,468
Cash flows from investing activities
Investments in property, plant and equipment
-492
-492
-1,059
-304
-190
Purchases of investments
-108,136
-108,136
-118,399
-
0
Sales/Maturities of investments
150,295
150,295
-
-
-
Net cash used for investing activites
41,667
41,667
-119,458
-304
-190
Cash flows from financing activities
Debt repayment
0
0
0
-212
-48
Common stock issued
0
0
106,472
-
0
Common stock repurchased
-59
-59
-
-
-5
Net cash used privided by (used for) financing activities
67
67
170,198
11,823
-53
Net change in cash
-4,647
-4,647
31,281
2,040
-5,711
Cash at beginning of period
45,473
45,473
14,192
12,152
17,863
Cash at end of period
40,826
40,826
45,473
14,192
12,152
Free Cash Flow
Operating Cash Flow
-46,381
-46,381
-19,459
-9,479
-5,468
Capital Expenditure
-492
-492
-1,059
-304
-190
Free Cash Flow
-46,873
-46,873
-20,518
-9,783
-5,658